by Metagenomic sequencing offers a complete understanding of the microorganisms present within communities by analyzing genetic material recovered directly from environmental samples. It provides taxonomic and functional analysis of all genetic material present in a sample without culturing. This technique is useful in various applications such as microbiome analysis, pathogen detection, and environmental/agricultural testing. The technique has revolutionized fields such as bioremediation, drug discovery, and personalized medicine. The rising adoption of metagenomic sequencing in clinical diagnosis and food quality control as well as advancements in DNA sequencing technologies are fueling market growth.
The Global Metagenomic Sequencing Market Size is estimated to be valued at US$ 1.41 Bn in 2024 and is expected to exhibit a CAGR of 17% over the forecast period 2024-2031.
Metagenomic sequencing leverages high-throughput sequencing platforms for culture-independent genomic analysis. It helps gain functional understanding of the totality of genomes present in natural and man-made microbial communities. Moreover, it aids antibiotic discovery, pollution bioremediation efforts, and boosting biofuel production. The technique is also used in species identification, disease outbreak preparedness, forensic analysis, and biodefense initiatives.
Key Takeaways
– Key players operating in the Global Metagenomic Sequencing are Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, PerkinElmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, BaseClear, MR DNA (Molecular Research), Eurofins Scientific, Novogene Corporation, NuGEN Technologies, Takara Bio, Swift Biosciences, New England Biolabs, and CosmosID.
– Rapidly growing applications of metagenomic sequencing in areas of human gut microbiome analysis, environmental remediation, industrial biotechnology and disease research are fueling market growth.
– Several market players are expanding their geographic presence through collaborations and partnerships to better serve diversifying customer demand across regions.
Market Key Trends
Adoption of single cell sequencing techniques is helping gain deeper insights into microbial ecosystems. Single-cell sequencing aids analysis of species interactions, gene expression profiles of individual microbes, and characterization of rare organisms. It provides a high-resolution view of microbial communities and interactions compared to bulk metagenomic sequencing. Single cell genomics is expected to enable promising applications in healthcare, synthetic biology and industrial biotechnology.
Porter’s Analysis
Threat Of New Entrants: The threat of new entrants is moderate as it requires substantial capital investment and technology to sequence and analyze metagenomics data.
Bargaining Power Of Buyers: The bargaining power of buyers is moderate as metagenomics sequencing is a highly specialized service and buyers have limited options.
Bargaining Power Of Suppliers: The bargaining power of suppliers is moderate as suppliers need to compete for contracts from research organizations, pharmaceutical companies, microbiology testing labs.
Threat Of New Substitutes: The threat of new substitutes is low as metagenomics sequencing has advantages over microbial culture-based methods and targeted sequencing.
Competitive Rivalry: The market is facing competition from established global players.
Geographical Regions
North America accounts for the largest share of the global metagenomic sequencing market due to increasing R&D investments by pharmaceutical and biotechnology companies in the region.
Asia Pacific is expected to be the fastest-growing regional market during the forecast period due to rising genomic research activities, increasing healthcare expenditure, and growing collaborations between global market players and regional research institutes. Countries such as China and India are likely to offer lucrative opportunities.
What Are The Key Data Covered In This Global Metagenomic Sequencing Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Metagenomic Sequencing Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Metagenomic Sequencing Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Metagenomic Sequencing Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Metagenomic Sequencing Market vendors
FAQ’S
Q.1 What are the main factors influencing the Global Metagenomic Sequencing market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Metagenomic Sequencing Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Metagenomic Sequencing market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
